Autoimmune Toxicities Associated with the Administration of Antitumor Vaccines and Low-Dose Interleukin-2-Reference-Cited by-同舟云学术

Autoimmune Toxicities Associated with the Administration of Antitumor Vaccines and Low-Dose Interleukin-2

Published:2005-07 Issue:4 Volume:28 Page:412-419
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Chianese-Bullock Kimberly A,Woodson Elizabeth M. H,Tao Huimin,Boerner Scott A,Smolkin Mark,Grosh William W,Neese Patrice Y,Merrill Priscilla,Petroni Gina R,Slingluff Craig L

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference33 articles.

1. Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.;Rosenberg;N Engl J Med,1985

2. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone.;Rosenberg;N Engl J Med,1987

3. Constant-infusion recombinant interleukin-2 in adoptive immunotherapy of advanced cancer.;West;N Engl J Med,1987

4. Interleukin-2 and lymphokine-activated killer cell therapy of solid tumors: analysis of toxicity and management guidelines.;Margolin;J Clin Oncol,1989

5. Therapy of renal cell carcinoma with interleukin-2 and lymphokine-activated killer cells: phase II experience with a hybrid bolus and continuous infusion interleukin-2 regimen.;Parkinson;J Clin Oncol,1990

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitiligo expansion and extent correlate with durable response in anti‐programmed death 1 antibody treatment for advanced melanoma: A multi‐institutional retrospective study;The Journal of Dermatology;2020-04-10

2. Thyroid dysfunctions secondary to cancer immunotherapy;Journal of Endocrinological Investigation;2017-12-13

3. Improved survival and tumor control with Interleukin-2 is associated with the development of immune-related adverse events: data from the PROCLAIMSM registry;Journal for ImmunoTherapy of Cancer;2017-12

4. Taking a Stab at Cancer; Oncolytic Virus-Mediated Anti-Cancer Vaccination Strategies;Biomedicines;2017-01-04

5. A case of pembrolizumab-induced type-1 diabetes mellitus and discussion of immune checkpoint inhibitor-induced type 1 diabetes;Cancer Immunology, Immunotherapy;2016-10-19